Results 191 to 200 of about 1,335,871 (234)
Some of the next articles are maybe not open access.
The Lancet, 2019
BACKGROUND First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a programmed death ligand 1 (PD-L1) tumour proportion score (TPS) of 50% or greater.
T. Mok +250 more
semanticscholar +1 more source
BACKGROUND First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a programmed death ligand 1 (PD-L1) tumour proportion score (TPS) of 50% or greater.
T. Mok +250 more
semanticscholar +1 more source
Therapy of non-small cell lung cancer
Lung Cancer, 1995Several regimes can provide clinical answers and longer survival to patients with small cell carcinoma of the lungs who respond to treatment. Moreover there is frequently also suppression of pathological symptoms of the disease in these patients.
openaire +3 more sources
2019
Non-small cell lung cancer (NSCLC) is most common cause of cancer death in the world. Early detection, diagnosis and treatments are the essential strategies for increased overall survival of patients. Recently, staging of NSCLC is updated to 8th edition of TNM staging for NSCLC issued by the IASLC which affects to overall survival and treatment methods.
Apichat Tantraworasin +8 more
openaire +1 more source
Non-small cell lung cancer (NSCLC) is most common cause of cancer death in the world. Early detection, diagnosis and treatments are the essential strategies for increased overall survival of patients. Recently, staging of NSCLC is updated to 8th edition of TNM staging for NSCLC issued by the IASLC which affects to overall survival and treatment methods.
Apichat Tantraworasin +8 more
openaire +1 more source
2003
Lung cancer represents the leading cause of cancer mortality in the United States in both sexes [1]. With approximately 170, 000 people diagnosed in 2000, lung cancer accounts for almost a third of all cancer deaths. This is partly because of the strong correlation of survival with stage and because over twothirds of patients present with locally ...
E. E. W. Cohen, E. E. Vokes
openaire +1 more source
Lung cancer represents the leading cause of cancer mortality in the United States in both sexes [1]. With approximately 170, 000 people diagnosed in 2000, lung cancer accounts for almost a third of all cancer deaths. This is partly because of the strong correlation of survival with stage and because over twothirds of patients present with locally ...
E. E. W. Cohen, E. E. Vokes
openaire +1 more source
2000
Lung cancer is the number one cause of cancer deaths worldwide. According to the World Health Organization, over 660,000 new cases are diagnosed each year. According to the American Cancer Society, almost 180,000 new cases are diagnosed annually within the United States.
R. J. Hagge, A. Al-Sugair, R. E. Coleman
openaire +1 more source
Lung cancer is the number one cause of cancer deaths worldwide. According to the World Health Organization, over 660,000 new cases are diagnosed each year. According to the American Cancer Society, almost 180,000 new cases are diagnosed annually within the United States.
R. J. Hagge, A. Al-Sugair, R. E. Coleman
openaire +1 more source
Advanced Non–Small-Cell Lung Cancer
New England Journal of Medicine, 2017Chuanli, Ren, Chongxu, Han, Daxin, Wang
openaire +5 more sources